SCHEMBL7147869

SCHEMBL7147869

COc1cccc(C(=O)Nc2nc3c(OC)ccc(-c4cccs4)n3n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
KDM4E B2RXH2 5/20 0.56
ALDH1A1 P00352 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
HPGD P15428 3/20 0.56
NPSR1 Q6W5P4 2/20 0.56
LMNA P02545 1/20 0.52
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
RXFP1 Q9HBX9 1/20 0.45
JAK1 P23458 1/20 0.45
GAA P10253 1/20 0.44
PPARG P37231 1/20 0.44
NCOA2 Q15596 1/20 0.44
NCOA1 Q15788 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
MAPT P10636 3/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043536 0.90 MAPT (0.48) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7146666 0.90 ALDH1A1 (0.53) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7042535 0.89 CYP1A2 (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7148818 0.88 KDM4E (0.42) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7041685 0.85 GABRD (0.47) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7042500 0.85 MAPT (0.46) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7149095 0.85 MAPT (0.54) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7041864 0.83 HDAC6 (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7151229 0.80 KMT2A (0.51) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7145678 0.80 MAPT (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed